atorvastatin has been researched along with losartan potassium in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, AL; Cleland, JG; Coletta, AP; Loh, PH; Tin, L | 1 |
| Chiang, CK; Hsu, SP; Huang, JW; Hung, KY; Pai, MF; Peng, YS; Wu, KD; Yang, SY | 1 |
| Dounousi, E; Ioannou, K; Kelesidis, A; Kotzadamis, N; Papakonstantinou, S; Tsakiris, D; Tsouchnikas, I; Xanthopoulou, K | 1 |
| Mittal, A; Nand, N | 1 |
| Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M | 1 |
1 review(s) available for atorvastatin and losartan potassium
| Article | Year |
|---|---|
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Ceftriaxone; Dibenzazepines; Drug Repositioning; Epilepsy; Epilepsy, Post-Traumatic; Erythropoietin; Fingolimod Hydrochloride; GABA Agents; Gabapentin; Humans; Immunologic Factors; Inflammation; Interleukin 1 Receptor Antagonist Protein; Isoflurane; Levetiracetam; Losartan; Neuroprotective Agents; Oxidative Stress; Pregabalin; Pyrrolidinones; Sirolimus; Stroke; Topiramate; Translational Research, Biomedical; Vigabatrin | 2020 |
2 trial(s) available for atorvastatin and losartan potassium
| Article | Year |
|---|---|
Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects.
Topics: Aged; Anemia; Atorvastatin; Drug Synergism; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Prospective Studies; Pyrroles; Recombinant Proteins; Renal Dialysis; Tumor Necrosis Factor-alpha | 2009 |
Evaluation of Effect of Statins on Erythropoietin Resistance in Patients of Chronic Kidney Disease on Maintenance Haemodialysis.
Topics: Adult; Anemia; Atorvastatin; Erythropoietin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
3 other study(ies) available for atorvastatin and losartan potassium
| Article | Year |
|---|---|
Recent changes to FDA-approved labeling.
Topics: Acetamides; Aminoquinolines; Atazanavir Sulfate; Atorvastatin; Botulinum Toxins, Type A; Dosage Forms; Drug Labeling; Epoetin Alfa; Erythropoietin; Heptanoic Acids; Humans; Imiquimod; Insulin; Insulin Lispro; Mandelic Acids; Oligopeptides; Oseltamivir; Pyridines; Pyrroles; Recombinant Proteins; United States; United States Food and Drug Administration | 2004 |
Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902.
Topics: Anemia; Atorvastatin; Cardiology; Clinical Trials as Topic; Congresses as Topic; Darbepoetin alfa; Diuretics; Erythropoietin; Europe; Exercise Tolerance; Ferric Compounds; Ferric Oxide, Saccharated; Glucaric Acid; Heart Failure; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Societies, Medical; Xanthines | 2006 |
Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients.
Topics: Aged; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Erythropoietin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Prospective Studies; Pyrroles; Renal Dialysis | 2009 |